Newsroom

TOKYO--(BUSINESS WIRE)--Hello Freedom Co., Ltd. will exhibit at Anime Expo 2026, taking place in Los Angeles, California, USA, Thursday, July 2, to Sunday, July 5, 2026, with a joint booth "Victor Entertainment × Hello Freedom – LIVE, RE:ALITY" in collaboration with Victor Entertainment Co., Ltd. Based on the concept of "LIVE, RE:ALITY," the booth will introduce a new form of live entertainment that transcends the boundaries between the real and the virtual. Through XR live experiences, we will...

CHICAGO--(BUSINESS WIRE)--Please replace the release issued earlier today with the following corrected version that provides additional information regarding the inducement grants. The corrected release reads: XERIS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today anno...

紐約--(BUSINESS WIRE)--(美國商業資訊)-- Rosen Law Firm是一家全球投資人權益律師事務所，提醒於2024年2月29日至2024年4月1日（包括首尾兩日，以下稱「集體訴訟期間」）出售ChampionX Corporation（NASDAQ：CHX）普通股的投資人注意一項集體訴訟。ChampionX是一家全球性的化學解決方案、人工舉升系統，以及石油與天然氣鑽探和生產設備與技術供應商。 如欲了解更多資訊，請提交表格、寄送電子郵件給律師Phillip Kim，或致電866-767-3653與我們聯絡。 指控內容：Rosen Law Firm正在調查ChampionX Corporation（NASDAQ：CHX）是否就其業務營運情況誤導投資人。 根據訴訟內容，被告在整個集體訴訟期間未揭露重大資訊，致使ChampionX普通股股價遭人為壓低。2024年2月29日，ChampionX收到Schlumberger Limited提出的一項未公開且主動提出的收購要約，擬以每股36.70美元收購ChampionX全部已發行流通股份。2024年3月7日，Schlumber...

DENVER--(BUSINESS WIRE)--NUBURU, Inc. (NYSE American: BURU), una piattaforma integrata di nuova generazione per la difesa e la sicurezza a “duplice impiego”, oggi ha diffuso la seguente lettera di di Alessandro Zamboni, Presidente esecutivo del CdA e Co-amministratore delegato NUBURU, rivolta agli azionisti. Gentile azionista, desidero parlarle con la massima franchezza, perché la storia di ciò che NUBURU è diventata merita di essere ascoltata chiaramente, al di sopra del rumore. Un anno fa que...

CALGARY, Alberta--(BUSINESS WIRE)--Pembina Pipeline Corporation ("Pembina" or the "Company") (TSX: PPL; NYSE: PBA), today announced that it has entered into a non-binding Heads of Agreement (the "HOA") with the Government of Canada, the Province of Alberta, Trans Mountain Corporation, and Alberta Petroleum and Marketing Commission, to participate in a proposed nation-building energy infrastructure initiative intended to strengthen Canada's energy transportation network and expand market access...

LOS ANGELES--(BUSINESS WIRE)--Halon Entertainment returns to independent ownership following a management buyout from NEP Group....

TAIPEI, Taiwan--(BUSINESS WIRE)--Following the global launch of the "Go Healthy with Taiwan 2026" campaign at a press conference in Taiwan on May 27, the global initiative is now accepting proposals from innovators, startups, researchers, institutions, and organizations worldwide, including participants from the U.S. Participants are invited to leverage Taiwan's products, technologies, and business models to develop scalable health and wellness solutions. This year, a new Top 20 Mentorship Prog...

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your PicS N.V. (“PicS” or the “Company”) (NASDAQ:PICS) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.Investors have until August 4, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead pla...

ATENAS, Grecia--(BUSINESS WIRE)--Omilia, líder mundial en experiencia de cliente agéntica de aprendizaje automático, anunció hoy el nombramiento de Armando Trivellato como vicepresidente ejecutivo de crecimiento. Su función será liderar la estrategia de lanzamiento al mercado de la empresa en América Latina y la península ibérica. En su nueva función, Armando construirá la presencia comercial de Omilia en América Latina, España y Portugal, mercados donde la demanda empresarial por la automatiza...

ROCKVILLE, Md.--(BUSINESS WIRE)--HLB Subsidiary Immunomic Therapeutics Announces First Patient Dosed in Phase 1 Trial of Allergy Vaccine Candidate ITI-9001...